1. Home
  2. HWBK vs ORGO Comparison

HWBK vs ORGO Comparison

Compare HWBK & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HWBK

Hawthorn Bancshares Inc.

HOLD

Current Price

$39.43

Market Cap

253.0M

Sector

Finance

ML Signal

HOLD

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

HOLD

Current Price

$2.36

Market Cap

299.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HWBK
ORGO
Founded
1865
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
253.0M
299.8M
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
HWBK
ORGO
Price
$39.43
$2.36
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
12.6K
709.8K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
2.49%
N/A
EPS Growth
31.42
1600.00
EPS
0.83
N/A
Revenue
N/A
$564,169,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$26.27
P/E Ratio
$48.18
N/A
Revenue Growth
N/A
17.04
52 Week Low
$28.10
$2.04
52 Week High
$40.36
$7.08

Technical Indicators

Market Signals
Indicator
HWBK
ORGO
Relative Strength Index (RSI) 55.17 43.20
Support Level $33.50 $2.26
Resistance Level N/A $2.58
Average True Range (ATR) 1.56 0.11
MACD 0.06 0.00
Stochastic Oscillator 68.61 18.75

Price Performance

Historical Comparison
HWBK
ORGO

About HWBK Hawthorn Bancshares Inc.

Hawthorn Bancshares Inc is a financial holding company that, along with its subsidiary bank, provides commercial banking for small and mid sized businesses, including equipment, operating, commercial real estate and SBA loans, and personal banking services such as real estate mortgage lending, installment and consumer loans, certificates of deposit, and checking, savings and money market accounts. It has two segments, banking and wealth management, with the banking segment earning the majority of its revenue and conducting general banking business, offering checking and savings accounts, internet banking, debit cards, certificates of deposit, brokerage services and others. Its primary source of revenue is net interest income derived from lending and deposit taking activities.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: